Development and implementation of a multidisciplinary sepsis protocol.
Picard
Kathy M
KM
Beth Israel Deaconess Medical Center, Boston, Mass., USA.
O'Donoghue
Sharon C
SC
Young-Kershaw
Duane A
DA
Russell
Kristin J
KJ
D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002423:Cause of Death; D002985:Clinical Protocols; D003422:Critical Care / Q000458:organization & administration*; D019091:Critical Pathways / Q000458:organization & administration*; D003663:Decision Trees; D005440:Fluid Therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D024802:Nurse's Role; D010347:Patient Care Planning; D010348:Patient Care Team / Q000458:organization & administration*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011486:Protein C / Q000627:therapeutic use; D012121:Respiration, Artificial; D012307:Risk Factors; D018805:Sepsis / Q000175:diagnosis* / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D017749:Total Quality Management / Q000458:organization & administration; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D007004:Hypoglycemic Agents; D007328:Insulin; D011486:Protein C